The Verge · AIJun 4, 2026, 20:12 UTC+8

AI leaders call for tougher protections against AI-aided bioweapons

Dario Amodei, Sam Altman, and Mustafa Suleyman signed an open letter urging Congress to require synthetic DNA and RNA sellers to screen orders for risky sequences; the RSS snippet does not disclose bill text, enforcement timelines, or screening thresholds.

Why it matters: HKR-H/K/R all pass, but this is an open letter and policy ask, not enacted law. The bill text and timeline are not disclosed, keeping it in featured rather than p1.

Read the original ↗Export Markdown

Take

This letter moves the biosecurity fight to the right choke point: synthetic DNA and RNA orders. Dario Amodei, Sam Altman, and Mustafa Suleyman are asking Congress to require sellers to screen risky sequences; the snippet gives no bill text, enforcement timeline, or screening threshold.

I buy the direction, not the implied sufficiency. Model-side safety filters are easy to route around with open weights, prompt laundering, and multi-model workflows. Wet-lab access has fewer gates: vendors, orders, and sequences leave audit trails. The hard part is jurisdiction. A US rule does not cover offshore vendors, split orders, or benign-looking fragments assembled later. If Congress writes this as a vendor checkbox instead of a verifiable screening regime, the AI CEOs get moral cover and the risk just moves one hop downstream.

Source: The Verge · AI · theverge.com
Published: Jun 4, 2026, 20:12 UTC+8 · Jun 4, 2026